Back

Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients

17 May 2025 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms (2) Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Daniela Bursacovschi

Institute of Cardiology, Chisinau (Moldova (Republic of))

7 More presentations in this session

Presentation thumbnail
Deciphering doxorubicin-induced cardiotoxicity:insights at single-cell resolution
Mr J. Van Fraeyenhove (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Takotsubo syndrome stress induced heart failure syndrome with significant LVOT obstruction
Doctor D. Kutlesic Kurtovic (Nis, RS)
Abstract Slides Video
Presentation thumbnail
Nicotinamide-N-methyltransferase inhibition improves cardiac function and structure in a heart failure with preserved ejection fraction mouse model
Mr S. Li (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study
Doctor D. Faro (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Evaluating systemic vascular resistance in response to stress facilitates identification of heart failure
Professor D. Jakovljevic (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms (2)

The Event

Event poster

Heart Failure 2025

17 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Decoding chemotherapy-related cardiac dysfunction prediction: left ventricular strain imaging or HFA-ICOS score?
thumbnail
Congress Presentation
The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma
thumbnail
Congress Presentation
Novel biomarker-based machine learning model in personalized cardiotoxicity prediction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources